I agree with this 2D. Adding patients to the trial
Post# of 30027
Posted On: 11/12/2014 1:59:54 PM
I agree with this 2D. Adding patients to the trial to show additional value in early Alzheimer's. Developing a new version to add value. Also, keeping very hush hush tells me it's being shopped around and I am quite sure there is significant interest.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼